Evidence-Based treatment for rare solitary splenic metastasis of an ovarian carcinoma in a female patient
10.3760/cma.j.issn.1007-8118.2011.04.017
- VernacularTitle:卵巢癌术后孤立性脾转移循证治疗一例
- Author:
Peihua LU
;
Lv JI
;
Bing CAI
;
Zhiyang JIANG
;
Jian SUN
;
Zijun LIU
;
Kaiwang SHI
- Publication Type:Journal Article
- Keywords:
Ovarian carcinoma;
Solitary splenic metastasis;
Evidence-based treatment
- From:
Chinese Journal of Hepatobiliary Surgery
2011;17(4):328-330
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveEvidence-based medicine was used to make an individualized treatment plan for rare solitary splenic metastasis of an ovarian carcinoma in a female patient. MethodsAfter clinical problems were discovered, evidence was collected from the Cochrane Library, PubMed, EMBASE, ScienceDirect, CNKI and Wanfang databases according to our predefined search strategy. The search was done until October, 2009. The validity of the evidence was assessed. The evidence, combined with the doctor experience and the patient value, was applied to the patient. ResultsA total of 15 English literature and 11 Chinese literature were identified. A rational treatment plan was made upon a critical evaluation of the data. There were 5 review articles in PubMed, EMBASE and ScienceDirect databases and no RCT in the Cochrane Library. And there was one retrospective cohort study inCNKI and Wanfang databases. The others were all case reports. After 20 month follow-up, the treatment protocol was proven correct. Conclusion The patient has rare disease, and the evidence intension for the evidence-based medicine was low. It can not present the efficacy of the evidence-based medicine treatment sufficiently, though it could provide some suggestion for rare disease which was lack of large RCT for evidence-based Methods .
